Benitec Biopharma
BNTC
BNTC
5 hedge funds and large institutions have $337K invested in Benitec Biopharma in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$10K |
| 2 |
2
Morgan Stanley
New York
|
$232K |
| 3 |
RE
3
RBC Europe
London,
United Kingdom
|
$47 |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$94K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $232K | 29,338 | +648 | +2% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $94K | 11,863 | -9,729 | -45% |
|
|
3
UBS Group
Zurich,
Switzerland
| $10K | 1,302 | +1,302 | New |
|
|
4
JPMorgan Chase & Co
New York
| $1K | 66 | -34 | -34% |
|
|
RE
5
RBC Europe
London,
United Kingdom
| $47 | 6 | +6 | New |
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -87 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|